These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Value and practical management of anticoagulant therapy by subcutaneous injection of concentrated calcium heparinate]. Di Matteo J; Picard R; Cornu P; Vacheron A; Bousquet O Arch Mal Coeur Vaiss; 1968 May; 61(5):724-34. PubMed ID: 4971372 [No Abstract] [Full Text] [Related]
7. Implications of anticoagulant therapy. Ellison N; Jobes DR; Schwartz AJ Int Anesthesiol Clin; 1982; 20(4):121-35. PubMed ID: 6757142 [No Abstract] [Full Text] [Related]
8. [Subcutaneous calcium heparinate: a new heparin]. Desrochers Y Union Med Can; 1975 May; 104(5):722-8. PubMed ID: 1136066 [No Abstract] [Full Text] [Related]
9. [Remarks on the use of Ca heparinate by subcutaneous route in anticoagulant therapy]. Vivien P Phlebologie; 1973; 26(1):15-21. PubMed ID: 4724445 [No Abstract] [Full Text] [Related]
10. [Control of subcutaneous calcium-heparin therapy by the thrombodensitogram]. Porta A; Magni S; Camagna P; Donati M; Dinelli CA Minerva Med; 1985 Mar; 76(11):531-2. PubMed ID: 3982692 [No Abstract] [Full Text] [Related]
11. [Evaluation of heparin therapy: sensitivity of the various methods]. Merino J; González-Boullosa R; Benet I; García-Conde J Rev Clin Esp; 1978 Oct; 151(2):107-11. PubMed ID: 740979 [No Abstract] [Full Text] [Related]
12. [The use of heparin and fibrinolysin in patients with coronary arteriosclerosis]. Aleĭnikova LI Vrach Delo; 1966 Mar; 3():53-6. PubMed ID: 4230197 [No Abstract] [Full Text] [Related]
13. [Practical management of transcutaneous heparin therapy with concentrated calcium heparinate in the treatment and prevention of postoperativve thromboembolic disease]. Favre J; Schvingt E; Hollender LF Lyon Chir; 1971; 67(2):147-50. PubMed ID: 5557694 [No Abstract] [Full Text] [Related]
14. [Therapeutic heparinization by subcutaneous route with individualized adjustment of the injected dose and of the time schedule of administration]. Langer B; Montagnini AL; Kutner JM; Khoury V; Albers MT; Puech-Leão LE Rev Hosp Clin Fac Med Sao Paulo; 1984; 39(1):35-9. PubMed ID: 6484439 [No Abstract] [Full Text] [Related]
15. Evaluation of subcutaneous calcium heparin therapy in the treatment of thrombo-embolic disease. Hirsh J; O'Sullivan EF; Gallus AS; Martin M Med J Aust; 1970 Jan; 1(1):15-7. PubMed ID: 5436524 [No Abstract] [Full Text] [Related]
16. [Revival of heparin therapy (role of calcium heparinate administered intracutaneously]. Larcan A; Raby C; Streiff F; Calamai M; Alexandre P Presse Med (1893); 1968 Jan; 76(2):67-70. PubMed ID: 5638159 [No Abstract] [Full Text] [Related]
17. Guidelines for administering heparin. Thurber CF J Maine Med Assoc; 1974 Sep; 65(9):212-3. PubMed ID: 4413614 [No Abstract] [Full Text] [Related]
18. Comparison of activated recalcification and partial thromboplastin tests as controls of heparin therapy. Ray PK; Harper TA J Lab Clin Med; 1971 Jun; 77(6):901-7. PubMed ID: 5559859 [No Abstract] [Full Text] [Related]
19. [The biologic control of long-term heparin therapy in the light of 115 cases of patients treated with subcutaneous calcium heparinate]. Migne J; Monteil R Angeiologie; 1967; 19(5):27-31. PubMed ID: 5621969 [No Abstract] [Full Text] [Related]
20. [Comparison of various methods of heparin treatment]. Chojnowski K; Judkiewicz L; Ciszewski R; Majda J Pol Tyg Lek; 1985 Nov; 40(44):1232-4. PubMed ID: 3911186 [No Abstract] [Full Text] [Related] [Next] [New Search]